In Vivo Study of Natural Killer (NK) Cell Cytotoxicity Against Cholangiocarcinoma in a Nude Mouse Model
Authors:
- 23 June 2018
- journal article
- research article
- Published by International Institute of Anticancer Research in In Vivo
- Vol. 32 (4) , 771-781
Abstract
Background/Aim: Natural killer (NK) cells are one of the lymphocytes clinically used for various cancer types. Cytotoxicity of NK cells to cholangiocarcinoma (CC), however, has not yet been studied. Nor NK cell therapy against CC has been clinically applied. In this study, relevance of NK cell therapy for anti-tumor efficacy against CC was pre-clinically investigated. Materials and Methods: Human HuCCT-1 cells, an intrahepatic CC cell line, were xenografted into nude mice. The HuCCT-1 tumor-bearing nude mice then received multiple infusions of ex vivo-expanded human NK cells (SMT01) and in vivo cytotoxic activity of the NK cells against the CC cells was evaluated. Results: SMT01 infusion resulted in significant inhibition of the CC tumor growth. Body weight of the mice administrated with chemotherapy was found to be maintained at the lowest level among all treatment groups while all the SMT01 infusion groups well maintained their body weight. Conclusion: The present in vivo study demonstrates that NK cells contain cytolytic activity against cholangiocarcinoma and show beneficial effect of NK cell therapy in relevance to quality of life. Further investigation of the NK cell-based immunotherapy can be useful to determine cancer therapeutics for the specific tumor.Keywords
This publication has 24 references indexed in Scilit:
- NK cell-based immunotherapy for malignant diseasesCellular & Molecular Immunology, 2013
- Aberrant Hedgehog Ligands Induce Progressive Pancreatic Fibrosis by Paracrine Activation of Myofibroblasts and Ductular Cells in Transgenic ZebrafishPLOS ONE, 2011
- Characterization of rag1 mutant zebrafish leukocytesBMC Immunology, 2009
- Oncogenic KRAS Induces Progenitor Cell Expansion and Malignant Transformation in Zebrafish Exocrine PancreasGastroenterology, 2008
- NKG2D function protects the host from tumor initiationJournal of Experimental Medicine, 2005
- NK CELL RECOGNITIONAnnual Review of Immunology, 2005
- Effectiveness of Donor Natural Killer Cell Alloreactivity in Mismatched Hematopoietic TransplantsScience, 2002
- Identity of Leu-19 (CD56) leukocyte differentiation antigen and neural cell adhesion molecule.Journal of Experimental Medicine, 1989
- Natural killer cells mediate lysis of embryonal carcinoma cells lacking MHCNature, 1980
- Cytotoxicity against the K562 erythroleukemia cell line by human natural killer (NK) cells which do not bear free Fc receptors for IgGInternational Journal of Cancer, 1979